CDKN2A and cancer: These universal cancer pathways are involved in well-known cancer-related processes, including intracellular signalling, cell cycle control, apoptosis and DNA repair, and are associated with the most recurrently altered known drivers (TP53, CDKN2A, MYC, ERBB2, SMAD4, CDK6, KRAS; Supplementary Data 2).